Chase AIPricingFAQs
Display currency
Loading news…

Kimia Therapeutics

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Berkeley, California, United States Founded 2022 11-50 employees For Profit

Kimia is a drug discovery company applying high throughput precision chemistry in combination.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
15

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
15
IT spend
$179K

Company Info

Founded
2022
Employees
11-50
Operating status
Active
Company type
For Profit
Org types
company
Founders
3
News articles
4
HQ
Berkeley, California, United States
Region
San Francisco Bay Area, West Coast, Western US

Signals & Scores

Heat score
Low
Growth score
Low
Trend (7d)
-0.4
Trend (30d)
-1
Trend (90d)
0

Key People at Kimia Therapeutics

Co-Founder, President, and CEO
Co-Founder and Senior Director of Discovery Technology
Co-Founder and VP, Discovery Chemistry
15
professional contacts at Kimia Therapeutics
Contact execs at Kimia Therapeutics

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Kimia Therapeutics

Loading news…

FAQs about Kimia Therapeutics

People who checked this page also checked these

Browse the full Acquirezy directory.
Kimia Therapeutics - Company Profile, Full Acquisitions List, Funding and Investments